• Home
  • Commercial & Medical
  • AC Immune says early biomarker data are promising in Parkinson’s, but clinical benefit remains unclear

AC Immune says early biomarker data are promising in Parkinson’s, but clinical benefit remains unclear

Swiss biotech AC Immune, researching immunological treatments for neurodegenerative disorders, reported interim Parkinson’s disease data Thursday, suggesting it may slow the progression of the condition.

But the interpretation of its clinical endpoints remains unclear, particularly …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registeration number 16808844